Novartis India Limited (BOM:500672)
830.85
+0.45 (0.05%)
At close: Feb 12, 2026
Novartis India Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | - | 520.7 | 449.8 | 194.2 | 1,584 | 682.7 |
Short-Term Investments | - | 5,850 | 5,400 | 5,350 | 3,579 | 4,291 |
Cash & Short-Term Investments | 6,173 | 6,371 | 5,850 | 5,544 | 5,163 | 4,974 |
Cash Growth | 3.36% | 8.91% | 5.51% | 7.38% | 3.80% | -14.30% |
Accounts Receivable | - | 401.4 | 414.7 | 361.6 | 445.6 | 387.3 |
Other Receivables | - | 89 | 94.7 | 130 | 116.4 | 456.1 |
Receivables | - | 490.4 | 509.4 | 491.6 | 566.6 | 844 |
Inventory | - | 411.1 | 448.6 | 547.2 | 570.7 | 479.5 |
Prepaid Expenses | - | 24.7 | 18.9 | 29.5 | 38.5 | 24.9 |
Other Current Assets | - | 161.3 | 165.9 | 160.8 | 748.6 | 908.8 |
Total Current Assets | - | 7,458 | 6,993 | 6,773 | 7,087 | 7,231 |
Property, Plant & Equipment | - | 45.4 | 69.4 | 192.5 | 236.5 | 639.1 |
Long-Term Investments | - | - | - | - | - | 8.3 |
Long-Term Deferred Tax Assets | - | 154.8 | 153.7 | 158 | 271.8 | 302.7 |
Other Long-Term Assets | - | 1,820 | 2,034 | 2,706 | 1,974 | 1,838 |
Total Assets | - | 9,478 | 9,249 | 9,829 | 9,576 | 10,023 |
Accounts Payable | - | 514.7 | 615.9 | 596.7 | 722 | 552 |
Accrued Expenses | - | 297.9 | 356.7 | 343.3 | 562.6 | 203.9 |
Short-Term Debt | - | - | 0.2 | - | - | - |
Current Portion of Leases | - | 18.5 | 18.8 | 41.2 | 57.4 | 127 |
Current Income Taxes Payable | - | 134.4 | 74.8 | 60.8 | 82.6 | 121.8 |
Other Current Liabilities | - | 455 | 505.6 | 552.9 | 739.6 | 584.8 |
Total Current Liabilities | - | 1,421 | 1,572 | 1,595 | 2,164 | 1,590 |
Long-Term Leases | - | 32.1 | 50.7 | 173.9 | 182.7 | 497.8 |
Pension & Post-Retirement Benefits | - | 144.5 | 145.7 | 188.4 | 255.6 | 585.6 |
Other Long-Term Liabilities | - | 31.4 | 32.7 | 115.6 | 56.2 | 238.1 |
Total Liabilities | - | 1,629 | 1,801 | 2,073 | 2,659 | 2,911 |
Common Stock | - | 123.4 | 123.4 | 123.4 | 123.4 | 123.4 |
Retained Earnings | - | 7,690 | 7,288 | 7,597 | 6,779 | 6,982 |
Comprehensive Income & Other | - | 36.4 | 36.4 | 36 | 14.2 | 6.9 |
Shareholders' Equity | 7,751 | 7,850 | 7,448 | 7,757 | 6,917 | 7,112 |
Total Liabilities & Equity | - | 9,478 | 9,249 | 9,829 | 9,576 | 10,023 |
Total Debt | 40.5 | 50.6 | 69.7 | 215.1 | 240.1 | 624.8 |
Net Cash (Debt) | 6,133 | 6,320 | 5,780 | 5,329 | 4,923 | 4,349 |
Net Cash Growth | 3.73% | 9.34% | 8.46% | 8.25% | 13.19% | -15.07% |
Net Cash Per Share | 248.35 | 255.97 | 234.10 | 215.83 | 199.38 | 176.15 |
Filing Date Shares Outstanding | 24.68 | 24.69 | 24.69 | 24.69 | 24.69 | 24.69 |
Total Common Shares Outstanding | 24.68 | 24.69 | 24.69 | 24.69 | 24.69 | 24.69 |
Working Capital | - | 6,038 | 5,421 | 5,178 | 4,923 | 5,642 |
Book Value Per Share | 313.93 | 317.92 | 301.66 | 314.15 | 280.14 | 288.04 |
Tangible Book Value | 7,751 | 7,850 | 7,448 | 7,757 | 6,917 | 7,112 |
Tangible Book Value Per Share | 313.93 | 317.92 | 301.66 | 314.15 | 280.14 | 288.04 |
Buildings | - | - | 0.5 | 0.5 | 0.9 | 1.7 |
Machinery | - | - | 45.1 | 47.7 | 80.5 | 105.1 |
Leasehold Improvements | - | 37.9 | 40.1 | 46.3 | 46.3 | 91.2 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.